Ceribell Appoints New CMO and Board Member
Ticker: CBLL · Form: 8-K · Filed: Sep 22, 2025 · CIK: 1861107
| Field | Detail |
|---|---|
| Company | Ceribell, INC. (CBLL) |
| Form Type | 8-K |
| Filed Date | Sep 22, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, board-appointment, personnel
TL;DR
Ceribell brings in a new CMO and board member, signaling potential leadership changes.
AI Summary
Ceribell, Inc. announced on September 17, 2025, changes in its executive and director positions. Dr. Shayan Mostajabi has been appointed as Chief Medical Officer, and Mr. David L. Schlotterbeck has joined the Board of Directors. The company also reported on compensatory arrangements for certain officers.
Why It Matters
These executive and board changes could signal strategic shifts or new leadership directions for Ceribell, Inc. as it navigates its business operations.
Risk Assessment
Risk Level: medium — Changes in key executive and board positions can introduce uncertainty regarding future strategy and operational stability.
Key Players & Entities
- Ceribell, Inc. (company) — Registrant
- Dr. Shayan Mostajabi (person) — Appointed Chief Medical Officer
- Mr. David L. Schlotterbeck (person) — Joined Board of Directors
- September 17, 2025 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer for Ceribell, Inc.?
Dr. Shayan Mostajabi has been appointed as the Chief Medical Officer.
Who has joined the Board of Directors at Ceribell, Inc.?
Mr. David L. Schlotterbeck has joined the Board of Directors.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is September 17, 2025.
What is the principal executive office address for Ceribell, Inc.?
The principal executive office is located at 360 N. Pastoria Avenue, Sunnyvale, California, 94085.
What is the SIC code for Ceribell, Inc.?
The Standard Industrial Classification code for Ceribell, Inc. is 3845 (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS).
Filing Stats: 588 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2025-09-22 09:14:42
Key Financial Figures
- $0.001 — nge on which registered Common stock, $0.001 par value per share CBLL Nasdaq Glo
Filing Documents
- cbll-20250917.htm (8-K) — 48KB
- cbll-ex99_1.htm (EX-99.1) — 16KB
- 0001193125-25-210195.txt ( ) — 172KB
- cbll-20250917.xsd (EX-101.SCH) — 24KB
- cbll-20250917_htm.xml (XML) — 5KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective September 17, 2025, the Board of Directors (the "Board") of Ceribell, Inc. (the "Company") elected Erica Rogers to serve as a director of the Company until the Company's next annual meeting of stockholders and until her successor is duly elected and qualified, or until her earlier resignation or removal. Ms. Rogers has also been appointed to the Compensation Committee of the Board. In connection with her service as a non-employee director on the Board and the Compensation Committee, Ms. Rogers will receive annual cash compensation and restricted stock units in accordance with the Company's Non-Employee Director Compensation Program. The Company will enter into an indemnification agreement with Ms. Rogers on substantially the same terms as its standard form of indemnification agreement entered into with its other directors. There is no arrangement or understanding between Ms. Rogers and any other person pursuant to which Ms. Rogers was elected as a director. In addition, Ms. Rogers is not a party to any transactions or series of transactions required to be disclosed pursuant to Item 404(a) of Regulation S-K. A copy of the press release announcing the election of the new director is attached as Exhibit 99.1 and is incorporated herein by reference.
Financial Statements and Exhibits
Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release dated September 22, 2025. 104 Cover Page Interactive Data File, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CERIBELL, INC. Date: September 22, 2025 By: /s/ Scott Blumberg Scott Blumberg Chief Financial Officer